Republication de : Effect of oral steroids on olfactory function in chronic rhinosinusitis with nasal polyps - 29/09/21
pages | 6 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Aims |
The present study aimed to investigate the effects of oral steroids on olfactory disturbances in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Material and methods |
This is a prospective randomized non-blinded study. Selected CRSwNP patients (n=140), with hyposmia, were devided into two groups; group A received a 7-day course of oral steroids with a 12-weeks course of nasal steroids and douching; group B received a 12-weeks course of nasal steroids and douching. Assessment included Sniffin’ Sticks scores, visual analogue scale score for olfaction and discomfort (VASsmell, VASdis), the Sinonasal Outcome Test-22, Greek-version (SNOT22-Gr) and the endoscopic appearance (EAS).
Objectives |
The main objective was to compare the olfactory effect of the different therapy in group A and group B, at 2, 12 and 24 weeks. Accessory objectives included the comparison of EAS, VASdis and SNOT22-Gr between groups, the evaluation of the therapeutic outcome duration, and, the investigation of potential correlation between the evaluated parameters.
Results |
The 2-weeks evaluation showed a significant statistical difference (P<0.001) for all parameters except VASdis. Olfactory outcomes (Sniffin’ Sticks and VASsmell scale scores) were found significantly better in group A at the 24-weeks evaluation (P<0.001). Within groups, the therapeutic result remained stable between the 12-weeks and 24-weeks evaluation (P>0.05). Sniffin’ Sticks score was strongly correlated at 12-weeks evaluation with EAS (rho=0.58, P<0.001).
Conclusion |
Our results suggest that a combination treatment of oral and nasal steroids in well-selected patients with CRSwNP may result in early olfaction restoration with a possible long-term effect.
Le texte complet de cet article est disponible en PDF.Keywords : Chronic rhinosinusitis, Nasal polyps, Olfaction, Steroids, Dexamethasone
Plan
☆ | Cet article a fait l’objet d’une première publication dans les European Annals of Otorhinolaryngology, Head and Neck Diseases. Nous le republions ici dans les pages des Annales Françaises d’Otolaryngologie, son titre jumelé. Avec autorisation de l’éditeur. Pour la citation veuillez utiliser la référence de la première parution : European Annals of Otorhinolaryngology, Head and Neck Diseases, 138 (5) (2021) 343–348. j.anorl.2020.06.028. |
Vol 138 - N° 5
P. 349-354 - octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?